CureVac N.V. (ETR:5CV)
4.718
+0.002 (0.04%)
Aug 15, 2025, 5:35 PM CET
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
€564,722
Profits / Employee
€214,201
Market Cap
1.05B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
CureVac News
- 1 day ago - CureVac BV reports Q2 results - Seeking Alpha
- 1 day ago - CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Wallstreet:Online
- 1 day ago - CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Accesswire
- 1 day ago - CureVac's 2025 Mid-Year Financial Surge & Key Business Insights - Wallstreet:Online
- 1 day ago - EQS-News: CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Wallstreet:Online
- 8 days ago - GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled - Seeking Alpha
- 8 days ago - GSK to be paid up to £370 million after patent row settles in US - Evening Standard
- 8 days ago - CureVac settles patent dispute litigation with Pfizer and BioNTech - Reuters